Vivoryon Therapeutics N.V.
VVY.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €51,811 | €205,219 | €227,242 | €380,000 |
| - Cash | €9,365 | €18,562 | €26,555 | €14,661 |
| + Debt | €102 | €38 | €132 | €224 |
| Enterprise Value | €42,548 | €186,695 | €200,819 | €365,563 |
| Revenue | €0 | -€3,620 | €0 | €10,764 |
| % Growth | 100% | – | -100% | – |
| Gross Profit | -€147 | -€3,095 | -€161 | €9,030 |
| % Margin | – | 85.5% | – | 83.9% |
| EBITDA | -€20,335 | -€28,353 | -€28,170 | -€12,034 |
| % Margin | – | 783.2% | – | -111.8% |
| Net Income | -€20,568 | -€28,342 | -€28,156 | -€12,655 |
| % Margin | – | 782.9% | – | -117.6% |
| EPS Diluted | -0.79 | -1.12 | -1.28 | -0.63 |
| % Growth | 29.5% | 12.5% | -103.2% | – |
| Operating Cash Flow | -€19,174 | -€21,541 | -€21,794 | -€11,257 |
| Capital Expenditures | -€2 | -€514 | -€13 | -€28 |
| Free Cash Flow | -€19,176 | -€22,055 | -€21,807 | -€11,285 |